Overview
Investment Stage
Series A; Series B
Portfolio 2
| Date | Name | Website | Total Raised | Location |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see | Sign up to see |
| Dec 16, 2025 | Cellular Origins | cellularorigins.com | $40M |
Mentions in press and media 7
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Mar 11, 2026 | Vitestro Secures $70 Million to Revolutionize Blood Collection | Vitestro secured $70 million in Series B funding. This capital fuels autonomous robotic blood collection. The Aletta system automates venipuncture with AI, multimodal imaging, and robotics. It aims for precise, consistent blood draws. This ... |
| Mar 10, 2026 | Vitestro Raises $70M in Series B Funding | Vitestro, a Utrecht, the Netherlands-based medical robotics company, raised $70M in Series B funding. Backers included Labcorp Venture Fund, Mayo Clinic, and Sutter Health, new financial investors InterVest, MGFO, PGGM, Puma Venture Capital... |
| Mar 10, 2026 | Vitestro: $70 Million Raised To Advance Autonomous Robotic Blood Collection Technology | Vitestro, a Netherlands-based medical robotics company developing autonomous blood-drawing technology, has raised $70 million in an oversubscribed Series B financing round to accelerate development of its robotic phlebotomy platform and exp... |
| Dec 16, 2025 | Cellular Origins Raises USD 40M in Series A Funding | Cellular Origins, a Cambridge, UK-based company that enables the manufacturing of cell therapies at scale, raised USD 40M in Series A funding. The round was led by Johnson & Johnson, through its corporate venture capital organisation, J... |
| Oct 1, 2025 | Star Therapeutics Raises $125M in Series D Financing | Star Therapeutics, a San Francisca, CA-based clinical stage biotechnology company discovering and developing antibodies for bleeding disorders and other diseases, raised $125M Series D funding. The round was co-led by Sanofi Ventures and Vi... |
| Jun 4, 2025 | Akadeum Life Sciences Raises $20M+ in Funding | Akadeum Life Sciences, an Ann Arbor, MI-based company which specializes in buoyancy-based cell separation technology, raised $20M+ in funding. The round was led by Michigan Capital Network, with participation from Arboretum Ventures, NYBC V... |
Reviews 0
FAQ about NYBC Ventures
How many startups has NYBC Ventures invested in?
NYBC Ventures has 2 portfolio companies on Parsers VC, among them Cellular Origins.
What has the press written about NYBC Ventures?
Parsers VC has collected 7 articles mentioning NYBC Ventures, among them “Vitestro Secures $70 Million to Revolutionize Blood Collection” (Mar 11, 2026) and “Vitestro Raises $70M in Series B Funding” (Mar 10, 2026).
Is NYBC Ventures still active?
Yes, NYBC Ventures is active; its latest activity on Parsers VC dates from Oct 26, 2026.